Literature DB >> 2022644

Tissue- and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1.

J G Conboy1, J Y Chan, J A Chasis, Y W Kan, N Mohandas.   

Abstract

Protein 4.1, a multifunctional structural protein originally described as an 80-kDa component of the erythroid membrane skeleton, exhibits tissue- and development-specific heterogeneity in molecular weight, subcellular localization, and primary amino acid sequence. Earlier reports suggested that some of this impressive heterogeneity is generated by alternative RNA splicing (Conboy, J. G., Chan, J., Mohandas, N., and Kan, Y. W. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9062-9065; Tang, T. K., Leto, T., Marchesi, V. T., and Benz, E. J. (1990) J. Cell Biol. 110, 617-624). We have now completed a systematic analysis of 4.1 mRNA isoforms expressed in erythroid cells, and have generated an "alternative splicing map" which summarizes diagrammatically a multitude of polypeptide isoforms potentially generated by combinatorial splicing of nine alternative exons. Complex 5' splicing events yield mRNA isoforms that may initiate translation at different sites and thus generate elongated or truncated NH2 termini; elongated approximately 135-kDa and prototypical approximately 80-kDa species were detected in both erythrocytes and T-lymphocytes, but in very different ratios. Among the functional domains of 4.1 responsible for interaction with other membrane skeletal elements, four variants of the 10-kDa spectrin-actin-binding region and four variants of the putative 30-kDa glycophorin-binding region are predicted. Developmentally controlled alternative RNA splicing in the spectrin-actin-binding region may help regulate remodeling of membrane architecture and mechanical properties that occur during erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022644

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1.

Authors:  L D Walensky; S Blackshaw; D Liao; C C Watkins; H U Weier; M Parra; R L Huganir; J G Conboy; N Mohandas; S H Snyder
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  The N-terminal 209-aa domain of high molecular-weight 4.1R isoforms abrogates 4.1R targeting to the nucleus.

Authors:  C M Luque; M J Lallena; C M Pérez-Ferreiro; Y de Isidro; G De Cárcer; M A Alonso; I Correas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  A nonerythroid isoform of protein 4.1R interacts with components of the contractile apparatus in skeletal myofibers.

Authors:  A Kontrogianni-Konstantopoulos; S C Huang; E J Benz
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

4.  Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.

Authors:  P Gascard; W Nunomura; G Lee; L D Walensky; S W Krauss; Y Takakuwa; J A Chasis; N Mohandas; J G Conboy
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

5.  Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

Authors:  Victor C Hou; Robert Lersch; Sherry L Gee; Julie L Ponthier; Annie J Lo; Michael Wu; Chris W Turck; Mark Koury; Adrian R Krainer; Akila Mayeda; John G Conboy
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

6.  Changing patterns in cytoskeletal mRNA expression and protein synthesis during murine erythropoiesis in vivo.

Authors:  L L Peters; R A White; C S Birkenmeier; M L Bloom; S E Lux; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Erythrocyte tropomodulin isoforms with and without the N-terminal actin-binding domain.

Authors:  Weijuan Yao; Lanping Amy Sung
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

9.  Inhibition of protein 4.1 R and NuMA interaction by mutagenization of their binding-sites abrogates nuclear localization of 4.1 R.

Authors:  Subhendra N Mattagajasingh; Shu-Ching Huang; Edward J Benz
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

10.  Alternatively spliced exon 5 of the FERM domain of protein 4.1R encodes a novel binding site for erythrocyte p55 and is critical for membrane targeting in epithelial cells.

Authors:  Pil-Soo Seo; Jong-Jin Jeong; Lixiao Zeng; Christos G Takoudis; Brendan J Quinn; Anwar A Khan; Toshihiko Hanada; Athar H Chishti
Journal:  Biochim Biophys Acta       Date:  2008-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.